Nextcure to present at the jmp securities life sciences conference

Beltsville, md., june 08, 2022 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the jmp securities life sciences conference in new york city on wednesday, june 15th at 2 pm et.
NXTC Ratings Summary
NXTC Quant Ranking